Table 3.
Percent change in age-standardized, delay-adjusted incidence rates from 2019 to 2020, by cancer site and sex, using the November 2022 data submission.
| Races/ethnicities | Sex | Age | 2019 delayed ASIR (95% CI) | 2020 delayed ASIR (95% CI) | AAPC (95% CI) |
|---|---|---|---|---|---|
| All | Both | All | 7.73 (7.6 to 7.87) | 7.11 (6.99 to 7.24) | − 8.02 (− 10.43 to − 5.61) |
| All | Both | < 55 | 1.53 (1.46 to 1.61) | 1.46 (1.39 to 1.54) | − 4.58 (− 11.66 to 2.51) |
| All | Both | ≥ 55 | 30.56 (30.01 to 31.12) | 27.92 (27.38 to 28.46) | − 8.64 (− 11.02 to − 6.25) |
| All | Female | All | 6.4 (6.24 to 6.57) | 5.87 (5.71 to 6.03) | − 8.28 (− 11.61 to − 4.96) |
| All | Male | All | 9.4 (9.18 to 9.62) | 8.68 (8.47 to 8.89) | − 7.66 (− 10.78 to − 4.54) |
| All | Female | < 55 | 1.39 (1.29 to 1.49) | 1.34 (1.24 to 1.44) | − 3.6 (− 13.39 to 6.2) |
| All | Female | ≥ 55 | 24.85 (24.18 to 25.53) | 22.55 (21.9 to 23.2) | − 9.26 (− 12.82 to − 5.69) |
| All | Male | < 55 | 1.68 (1.57 to 1.8) | 1.59 (1.48 to 1.7) | − 5.36 (− 15 to 4.28) |
| All | Male | ≥ 55 | 37.8 (36.87 to 38.74) | 34.78 (33.88 to 35.7) | − 7.99 (− 11.3 to − 4.68) |
| Hispanic | Both | All | 7.21 (6.88 to 7.56) | 6.55 (6.24 to 6.88) | − 9.15 (− 15.2 to − 3.11) |
| Hispanic | Both | < 55 | 1.29 (1.16 to 1.44) | 1.38 (1.24 to 1.53) | 6.98 (− 8.6 to 22.55) |
| Hispanic | Both | ≥ 55 | 29 (27.53 to 30.53) | 25.61 (24.24 to 27.03) | − 11.69 (− 18.29 to − 5.09) |
| Hispanic | Female | all | 6.16 (5.75 to 6.59) | 5.37 (5 to 5.77) | − 12.82 (− 21.45 to − 4.2) |
| Hispanic | Female | < 55 | 1.24 (1.05 to 1.44) | 1.29 (1.1 to 1.5) | 4.03 (− 18.78 to 26.84) |
| Hispanic | Female | ≥ 55 | 24.28 (22.5 to 26.16) | 20.41 (18.8 to 22.11) | − 15.94 (− 25.2 to − 6.68) |
| Hispanic | Male | All | 8.57 (8.02 to 9.15) | 8.07 (7.54 to 8.63) | − 5.83 (− 14.78 to 3.11) |
| Hispanic | Male | < 55 | 1.35 (1.16 to 1.56) | 1.47 (1.27 to 1.69) | 8.89 (− 13.58 to 31.36) |
| Hispanic | Male | ≥ 55 | 35.15 (32.67 to 37.76) | 32.39 (30.03 to 34.88) | − 7.85 (− 17.39 to 1.69) |
| NHB | Both | All | 16.05 (15.44 to 16.68) | 14.29 (13.71 to 14.89) | − 10.97 (− 15.94 to − 5.99) |
| NHB | Both | < 55 | 3.58 (3.25 to 3.93) | 3.42 (3.09 to 3.76) | − 4.47 (− 17.34 to 8.4) |
| NHB | Both | ≥ 55 | 61.97 (59.39 to 64.64) | 54.3 (51.86 to 56.81) | − 12.38 (− 17.81 to − 6.95) |
| NHB | Female | All | 14.14 (13.39 to 14.93) | 12.69 (11.97 to 13.43) | − 10.25 (− 17.31 to − 3.19) |
| NHB | Female | < 55 | 3.37 (2.94 to 3.84) | 3.29 (2.86 to 3.77) | − 2.37 (− 21.07 to 16.32) |
| NHB | Female | ≥ 55 | 53.8 (50.69 to 57.05) | 47.29 (44.36 to 50.35) | − 12.1 (− 19.67 to − 4.53) |
| NHB | Male | All | 18.78 (17.74 to 19.85) | 16.73 (15.74 to 17.77) | − 10.92 (− 18.23 to − 3.6) |
| NHB | Male | < 55 | 3.82 (3.33 to 4.35) | 3.56 (3.08 to 4.08) | − 6.81 (− 24.67 to 11.06) |
| NHB | Male | ≥ 55 | 73.84 (69.36 to 78.53) | 65.23 (60.95 to 69.71) | − 11.66 (− 19.68 to − 3.64) |
| NHW | Both | All | 6.95 (6.8 to 7.11) | 6.45 (6.3 to 6.6) | − 7.19 (− 10.27 to − 4.12) |
| NHW | Both | < 55 | 1.28 (1.18 to 1.37) | 1.18 (1.09 to 1.28) | − 7.81 (− 18.23 to 2.6) |
| NHW | Both | ≥ 55 | 27.85 (27.21 to 28.5) | 25.83 (25.2 to 26.47) | − 7.25 (− 10.37 to − 4.14) |
| NHW | Female | All | 5.5 (5.31 to 5.7) | 5.08 (4.9 to 5.27) | − 7.64 (− 12.49 to − 2.79) |
| NHW | Female | < 55 | 1.07 (0.95 to 1.21) | 0.99 (0.87 to 1.12) | − 7.48 (− 22.45 to 7.5) |
| NHW | Female | ≥ 55 | 21.8 (21.03 to 22.59) | 20.14 (19.39 to 20.91) | − 7.61 (− 12.32 to − 2.91) |
| NHW | Male | All | 8.71 (8.45 to 8.97) | 8.11 (7.85 to 8.36) | − 6.89 (− 10.89 to − 2.89) |
| NHW | Male | < 55 | 1.48 (1.34 to 1.63) | 1.37 (1.24 to 1.52) | − 7.43 (− 20.06 to 5.2) |
| NHW | Male | ≥ 55 | 35.33 (34.25 to 36.44) | 32.89 (31.83 to 33.96) | − 6.91 (− 11.07 to − 2.74) |
NHW Non-Hispanic White, NHB Non-Hispanic Black, ASIR Age-standardized incidence rate, CI Confidence interval, AAPC Average annual percent change.